Kazia Therapeutics : EXPANDS BOARD OF DIRECTORS WITH APPOINTMENT OF EBRU DAVIDSON - Form 6-K
KAZIA EXPANDS BOARD OF DIRECTORS WITH APPOINTMENT OF EBRU DAVIDSON Ms Ebru Davidson appointed as a Non-Executive Director Sydney, 5th June... | June 5, 2023
Stay updated with breaking news from Initial Director. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KAZIA EXPANDS BOARD OF DIRECTORS WITH APPOINTMENT OF EBRU DAVIDSON Ms Ebru Davidson appointed as a Non-Executive Director Sydney, 5th June... | June 5, 2023
Investegate announcements from Castillo Copper Ltd, Initial and Final Director's Interest Notices
Telix Pharmaceuticals Limited announces that Tiffany Olson has been appointed to the Board, as a U.S.-based independent, Non-Executive Director. Ms. Olson brings a depth of experience in commercialisation and corporate strategy in oncology, including in the radiopharmaceutical sector. Her most recent executive role was with Cardinal Health, the largest provider of radiopharmaceuticals in the United States,
Investegate announcements from Castillo Copper Ltd, Appendix 3X - Initial Director's Interest Notice
Non-Executive Director Oliver Buck to retire at the Annual General Meeting Tiffany Olson, experienced U.S.-based pharma executive appointed as independent Non-Executive...